Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991 Oct;81(10):1273-9.
doi: 10.2105/ajph.81.10.1273.

Bleach programs for preventing AIDS among i.v. drug users: modeling the impact of HIV prevalence

Affiliations

Bleach programs for preventing AIDS among i.v. drug users: modeling the impact of HIV prevalence

J E Siegel et al. Am J Public Health. 1991 Oct.

Abstract

Background: The growing importance of drug use as a mode of HIV transmission has led to increased attention to AIDS prevention among intravenous drug users (IVDUs). This analysis examines the effectiveness of bleach distribution, a program to prevent HIV transmission via shared needles.

Methods: We used a Markov model to assess the role of the initial HIV prevalence among drug users in determining the effectiveness of bleach programs. The model incorporates survey data on risk behaviors and published information describing HIV incubation and mortality. It predicts life expectancy for cohorts of IVDUs with and without a bleach program to estimate program effectiveness.

Results: We found that bleach programs can produce the greatest life-year savings in areas of low HIV prevalence. In the lowest prevalence scenario (0.02 initial prevalence), initiation of the program resulted in a projected savings of 2.3 life years per HIV-negative drug user, compared with 1.7 and 1.3 years under medium (0.25) and high (0.60) prevalence, respectively.

Conclusions: While bleach programs are beneficial in all groups of IVDUs, these results highlight the advantages of introducing bleach programs early, when prevalence is still comparatively low in a drug-user population.

PubMed Disclaimer

References

    1. J Acquir Immune Defic Syndr. 1989;2(1):84-7 - PubMed
    1. Science. 1988 Nov 11;242(4880):916-9 - PubMed
    1. Rev Infect Dis. 1989 Mar-Apr;11(2):289-98 - PubMed
    1. AIDS. 1989 Jun;3(6):333-46 - PubMed
    1. N Engl J Med. 1989 Sep 28;321(13):874-9 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources